| Saliva-based molecular testing for SARS-CoV-2 that bypasses RNA extraction DRE Ranoa, RL Holland, FG Alnaji, KJ Green, L Wang, CB Brooke, ... biorxiv, 2020.06. 18.159434, 2020 | 119 | 2020 |
| Sequencing framework for the sensitive detection and precise mapping of defective interfering particle-associated deletions across influenza A and B viruses FG Alnaji, JR Holmes, G Rendon, JC Vera, CJ Fields, BE Martin, ... Journal of virology 93 (11), 10.1128/jvi. 00354-19, 2019 | 50 | 2019 |
| Influenza virus DI particles: Defective interfering or delightfully interesting? FG Alnaji, CB Brooke PLoS pathogens 16 (5), e1008436, 2020 | 40 | 2020 |
| Mitigation of SARS-CoV-2 transmission at a large public university DRE Ranoa, RL Holland, FG Alnaji, KJ Green, L Wang, RL Fredrickson, ... Nature communications 13 (1), 3207, 2022 | 34 | 2022 |
| Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy L Pelz, D Rüdiger, T Dogra, FG Alnaji, Y Genzel, CB Brooke, SY Kupke, ... Journal of Virology 95 (24), 10.1128/jvi. 01174-21, 2021 | 22 | 2021 |
| Imprecise recombinant viruses evolve via a fitness-driven, iterative process of polymerase template-switching events K Bentley, FG Alnaji, L Woodford, S Jones, A Woodman, DJ Evans PLoS pathogens 17 (8), e1009676, 2021 | 19 | 2021 |
| Influenza A virus defective viral genomes are inefficiently packaged into virions relative to wild-type genomic RNAs FG Alnaji, WK Reiser, J Rivera-Cardona, AJW Te Velthuis, CB Brooke Mbio 12 (6), e02959-21, 2021 | 16 | 2021 |
| Generated randomly and selected functionally? The nature of enterovirus recombination FG Alnaji, K Bentley, A Pearson, A Woodman, J Moore, H Fox, ... Viruses 14 (5), 916, 2022 | 13* | 2022 |
| Saliva-based molecular testing for SARS-CoV-2 that bypasses RNA extraction. bioRxiv DRE Ranoa, RL Holland, FG Alnaji, KJ Green, L Wang, CB Brooke, ... Preprint posted online 18, 2020 | 13 | 2020 |
| Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection M Farjo, K Koelle, MA Martin, LL Gibson, KKO Walden, G Rendon, ... Journal of virology 98 (1), e01618-23, 2024 | 8 | 2024 |
| Saliva-Based Molecular Testing for SARS-CoV-2 that Bypasses RNA Extraction. bioRxiv. 2020: 2020.06. 18.159434 DRE Ranoa, RL Holland, FG Alnaji, KJ Green, L Wang, CB Brooke View Article, 0 | 5 | |
| Cryptic proteins translated from deletion-containing viral genomes dramatically expand the influenza virus proteome JN Ranum, MP Ledwith, FG Alnaji, M Diefenbacher, R Orton, E Sloan, ... Nucleic acids research 52 (6), 3199-3212, 2024 | | 2024 |
| Saliva-based molecular testing for SARS-CoV-2 DR Ranoa, RL Holland, FG Alnaji, KJ Green, L Wang, CB Brooke, ... US Patent 11,926,877, 2024 | | 2024 |
| Fitness adaptations of Japanese encephalitis virus in pigs following vector-free serial passaging A Marti, A Nater, J Pego Magalhaes, L Almeida, M Lewandowska, ... bioRxiv, 2024.02. 20.581151, 2024 | | 2024 |
| Saliva-based Molecular Testing For SARS-CoV-2 MD Burke, TM Fan, PJ Hergenrother, CB Brooke, DRE Ranoa, ... | | 2022 |
| Saliva-based molecular testing for SARS-CoV-2 DR Ranoa, RL Holland, FG Alnaji, KJ Green, L Wang, CB Brooke, ... US Patent 11,530,457, 2022 | | 2022 |
| Influenza A virus-derived defective interfering particles for antiviral treatment SY Kupke, MD Hein, Y Genzel, L Pelz, P Marichal-Gallardo, N Bdeir, ... | | 2022 |
| Long-term propagation of influenza A virus and its defective interfering particles: Analyzing dynamic competition to select antiviral candidates L Pelz, D Rüdiger, T Dogra, FG Alnaji, Y Genzel, CB Brooke, SY Kupke, ... | | 2022 |
| Mitigation of SARS-CoV-2 Transmission at a Large Public University (preprint) DRE Ranoa, RL Holland, FG Alnaji, KJ Green, L Wang, RL Fredrickson, ... | | 2021 |
| Saliva-Based Molecular Testing for SARS-CoV-2 that Bypasses RNA Extraction (preprint) D Ranoa, R Holland, FG Alnaji, K Green, L Wang, C Brooke, M Burke, ... | | 2020 |
